Nucleus accumbens has been reported as a key structure in the neurobiology of schizophrenia. Studies analyzing structural abnormalities have shown conflicting results, possibly related to confounding factors. We investigated the nucleus accumbens volume using manual delimitation in first-episode psychosis (FEP) controlling for age, cannabis use and medication. Thirty-one FEP subjects who were naive or minimally exposed to antipsychotics and a control group were MRI scanned and clinically assessed from baseline to 6 months of follow-up. FEP showed increased relative and total accumbens volumes. Clinical correlations with negative symptoms, duration of untreated psychosis and cannabis use were not significant.
Introduction
Several studies have suggested the reward system in general, and the nucleus accumbens in particular, as a key role in the neurobiology of schizophrenia. The nucleus accumbens seems to be implicated in the association of stimulus with subsequent reward, generating a process of reinforcement learning (stimulus-reward learning) which is implicated in every-day actions (Berridge and Robinson, 1998) . Its dysfunction could explain both aberrant salience attribution, which is thought to underlie delusions (Morrison and Murray, 2009) , and an inability to process rewards from everyday life, causing amotivation (Waltz and Gold, 2016) , one of the central domains of negative symptoms in schizophrenia.
To date, brain imaging studies investigating the structure and volume of the nucleus accumbens in patients with psychosis have shown controversial results, including increased nucleus accumbens volume in post-mortem schizophrenic subjects (Mamah et al., 2007; Spoletini et al., 2011; Tamagaki et al., 2005; Womer et al., 2014) , decreased or no differences in first episode psychosis in relation to control subjects (Ballmaier et al., 2008; Glenthoj et al., 2007; Gunduz et al., 2002) . Also, attempts to study possible confounding factors have found increased, decreased or no change with typical or atypical antipsychotics (Boonstra et al., 2011; Ebdrup et al., 2010; Smieskova et al., 2009) , and basal ganglia volumes increases or decreases associated to cannabis use (Gilman et al., 2014; Yücel et al., 2008) .
The present study was designed to measure manually the volumes of the nuclei accumbens in a sample of early diagnosed FEP compared to a control group, controlling for cannabis use, course of illness and medication. We also aimed to determine the degree of association between accumbens volume and clinical features. We hypothesized that first-episode psychosis patients would show reduced accumbens volumes, compared to those of healthy controls. Additionally, we hypothesized that the reduction in accumbens volumes would be associated with more negative symptoms at baseline and during follow-up.
Methods
Thirty-one antipyshcotic-naive FEP were recruited between 2008 and 2012 from the emergency service and the inpatient acute ward of Hospital del Mar in Barcelona. Other inclusion criteria were age between 18 and 30 years, absence of severe neurological disorder or head trauma and absence of severe stimulants, opioid or alcohol dependence. Twenty-seven healthy controls without any present axis I disorder or any past severe mental disorder were also recruited. 
